acetic acid and sildenafil citrate

acetic acid has been researched along with sildenafil citrate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Jain, NK; Kulkarni, SK; Patil, CS; Singh, A1
Jain, NK; Kulkarni, SK; Patil, CS; Singh, VP1
Naidong, W; Shou, WZ1
Alican, I; Atukeren, P; Ercan, F; Ersoy, Y; Gumustas, K; Iseri, SO; Yuksel, M1
Akkoc, RF; Aksoy, A; Artas, G; Aydin, S; Dalkilic, S; Gursu, O; Kalayci, M; Kocdor, MA; Kuloglu, T; Ozercan, İH; Sahin, İ; Sarac, M; Ugras, M; Ugur, K; Yardim, M1
Abdelrahman, RS; El-Tanbouly, GS1

Other Studies

6 other study(ies) available for acetic acid and sildenafil citrate

ArticleYear
Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway.
    Brain research, 2001, Aug-03, Volume: 909, Issue:1-2

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Acetic Acid; Analgesia; Animals; Arginine; Carrageenan; Central Nervous System; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Female; Hyperalgesia; Male; Methylene Blue; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Nociceptors; Pain; Pain Measurement; Pain Threshold; Peripheral Nervous System; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Signal Transduction; Sildenafil Citrate; Sulfones

2001
Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception.
    Indian journal of experimental biology, 2004, Volume: 42, Issue:4

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Acetic Acid; Acetylcholine; Animals; Carrageenan; Cholinergic Agents; Cholinesterase Inhibitors; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Female; Guanylate Cyclase; Hyperalgesia; Male; Methylene Blue; Mice; Neostigmine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pain; Pain Measurement; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Sildenafil Citrate; Sulfones

2004
Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric (HILIC-ESI/MS/MS) bioanalysis of basic compounds.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005, Oct-25, Volume: 825, Issue:2

    Topics: Acetic Acid; Chromatography, Liquid; Cotinine; Ethionamide; Fluconazole; Humans; Isoniazid; Nicotine; Piperazines; Propionates; Purines; Pyrazinamide; Sensitivity and Specificity; Sildenafil Citrate; Spectrometry, Mass, Electrospray Ionization; Sulfones; Trifluoroacetic Acid

2005
The effect of sildenafil, a phosphodiesterase-5 inhibitor, on acetic acid-induced colonic inflammation in the rat.
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:6

    Topics: Acetic Acid; Analysis of Variance; Animals; Colitis; Glutathione; Interleukin-1beta; Luminescence; Malondialdehyde; Microscopy, Electron, Scanning; Peroxidase; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Statistics, Nonparametric; Sulfones; Tumor Necrosis Factor-alpha

2009
Comparison of the therapeutic effects of sildenafil citrate, heparin and neuropeptides in a rat model of acetic acid-induced gastric ulcer.
    Life sciences, 2017, Oct-01, Volume: 186

    Topics: Acetic Acid; Animals; Anti-Ulcer Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Gastric Mucosa; Heparin; Neuropeptides; Rats, Sprague-Dawley; Sildenafil Citrate; Stomach Ulcer

2017
The emerging coloprotective effect of sildenafil against ulcerative colitis in rats via exerting counterbalance between NF-κB signaling and Nrf-2/HO-1 pathway.
    Inflammopharmacology, 2022, Volume: 30, Issue:4

    Topics: Acetic Acid; Animals; Colitis, Ulcerative; Colon; Dexamethasone; NF-kappa B; Rats; Sildenafil Citrate; Tumor Necrosis Factor-alpha

2022